BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30271628)

  • 21. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual Acuity in Retinal Vein Occlusion, Diabetic, and Uveitic Macular Edema: Central Subfield Thickness and Ellipsoid Zone Analysis.
    Ciulla TA; Kapik B; Grewal DS; Ip MS
    Ophthalmol Retina; 2021 Jul; 5(7):633-647. PubMed ID: 33130256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
    Tang F; Qin X; Lu J; Song P; Li M; Ma X
    Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant.
    Busch C; Rehak M; Sarvariya C; Zur D; Iglicki M; Lima LH; Invernizzi A; Viola F; Agrawal K; Sinawat S; Couturier A; Mehta A; Juneja R; Jain H; Agarwal AK; Goel N; Nagpal M; Gupta V; Banker A; Loewenstein A; Okada M; Saatci AO; Mansour AM; Chhablani J
    Br J Ophthalmol; 2019 Apr; 103(4):463-468. PubMed ID: 29891733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.
    Kuppermann BD; Haller JA; Bandello F; Loewenstein A; Jiao J; Li XY; Whitcup SM
    Retina; 2014 Sep; 34(9):1743-9. PubMed ID: 24830824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OUTER RETINAL LAYER CHANGES AFTER DEXAMETHASONE IMPLANT FOR CENTRAL RETINAL VEIN OCCLUSION.
    Battaglia Parodi M; Iacono P; Scaramuzzi M; Bandello F
    Retina; 2017 Oct; 37(10):1888-1895. PubMed ID: 28030428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion.
    Parodi MB; Iacono P; De Benedetto U; Cascavilla M; Bandello F
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):566-8. PubMed ID: 22746671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea.
    Kim MS; Choi J; Lee HD; Woo SJ;
    Clin Ophthalmol; 2021; 15():3623-3636. PubMed ID: 34475750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jiao J; Li XY; Whitcup SM; ; Li J
    Ophthalmology; 2011 Dec; 118(12):2453-60. PubMed ID: 21764136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Efficacy and Safety of Intravitreal Dexamethasone Implant for the Treatment of Macular Edema Related to Retinal Vein Occlusion: Real-life Data and Prognostic Factors in a Turkish Population.
    Kanra AY; Ardagil Akçakaya A; Arı Yaylalı S; Altınel MG; Sevimli N
    Turk J Ophthalmol; 2017 Dec; 47(6):331-337. PubMed ID: 29326850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
    Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Singer MA; Capone A; Dugel PU; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Apr; 15():33. PubMed ID: 25885285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
    Hu Q; Li H; Xu W; Du Y; Ma C; He J
    Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study.
    Lam WC; Albiani DA; Yoganathan P; Chen JC; Kherani A; Maberley DA; Oliver A; Rabinovitch T; Sheidow TG; Tourville E; Wittenberg LA; Sigouin C; Baptiste DC
    Clin Ophthalmol; 2015; 9():1255-68. PubMed ID: 26203215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The usefulness of the retinal sensitivity measurement with a microperimetry for predicting the visual prognosis of branch retinal vein occlusion with macular edema.
    Fujino R; Asaoka R; Aoki S; Sugiura A; Kusakabe M; Asano-Shimizu K; Nomura Y; Aoki A; Hashimoto Y; Azuma K; Inoue T; Obata R
    Graefes Arch Clin Exp Ophthalmol; 2020 Sep; 258(9):1949-1958. PubMed ID: 32458100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Dexamethasone Intravitreal Implant on Visual Acuity and Foveal Photoreceptor Integrity in Macular Edema Secondary to Retinal Vascular Disease.
    Castro-Navarro V; Monferrer-Adsuara C; Navarro-Palop C; Montero-Hernández J; Cervera-Taulet E
    Ophthalmologica; 2021; 244(1):83-92. PubMed ID: 33045712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of Intravitreal Corticosteroid with Anti-vegf in Macular Edema Secondary to Retinal Vein Occlusion.
    Valašková J; Popov I; Krásnik V
    Cesk Slov Oftalmol; 2018; 73(5-6):183-188. PubMed ID: 30541298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of morphologic and functional parameter changes post intravitreal therapy for macular edema.
    Sharief L; Chen YH; Lightman S; Tomkins-Netzer O
    Graefes Arch Clin Exp Ophthalmol; 2020 Sep; 258(9):1941-1947. PubMed ID: 32361803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion.
    Pichi F; Specchia C; Vitale L; Lembo A; Morara M; Veronese C; Ciardella AP; Nucci P
    Am J Ophthalmol; 2014 Mar; 157(3):607-15.e1. PubMed ID: 24528934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
    Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
    Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.